Team

We're an interdisciplinary, collaborative team with a mission to transform protein therapeutics discovery.

Gleb Kuznetsov, PhD

Gleb Kuznetsov, PhD

Co-Founder & CEO

 Pierce Ogden, PhD

Pierce Ogden, PhD

Co-Founder & CSO

Shane Lofgren

Shane Lofgren

Co-Founder & Head of Business Development

George Church, PhD

George Church, PhD

Co-Founder

Kate Nudel, PhD

Kate Nudel, PhD

Associate Director, Head of Applied Biology

Hoong Chuin Lim, PhD

Hoong Chuin Lim, PhD

Associate Director, Head of Barcoding Platform

Anisha Anand

Anisha Anand

Associate Scientist

Karen Duffy, PhD

Karen Duffy, PhD

Senior Scientist

Alex Reis, PhD

Alex Reis, PhD

Senior Scientist

 Alvaro García, PhD

Alvaro García, PhD

Associate Director, Head of In Vivo

John Avera

John Avera

Scientist

Roasa Mehmood, MS

Roasa Mehmood, MS

Associate Scientist

 Molly Zawacki

Molly Zawacki

Senior Operations Associate

Mike Nichols, PhD

Mike Nichols, PhD

Scientist

Anca Ioana Stoica

Anca Ioana Stoica

Research Associate

Alex Gerew

Alex Gerew

Associate Scientist

Jack Gourdeau

Jack Gourdeau

Research Associate

Supriya Ravichandran, PhD

Supriya Ravichandran, PhD

Senior Scientist

Sal Alioto, PhD

Sal Alioto, PhD

Principal Scientist

Fabliha Anam, MS

Fabliha Anam, MS

Research Associate

Chen Wang

Chen Wang

Associate Director, Head of Lab Operations

Ainaz Malekoltojari, MS

Ainaz Malekoltojari, MS

Senior Research Associate

Sierra Goodrich

Sierra Goodrich

Office Manager

Glenn Hauk, PhD

Glenn Hauk, PhD

Senior Scientist

Yendee Ho-Rath

Yendee Ho-Rath

Research Associate

Jeffrey Chang

Jeffrey Chang

Biophysics / Statistical Modeling Consultant

Advisors

Advisors

Alex Lugovskoy, PhD

SAB, Protein Therapeutics Discovery and Development

EIR, Atlas Venture

Dennis Benjamin, PhD

SAB, Protein Therapeutics Discovery and Development

N/A

Seth Ettenberg, PhD

Strategic Advisor, Platform Build and Partnering

CEO, Bluerock Therapeutics

Ryan P. Adams, PhD

SAB, Machine Learning-guided Design

Professor of Computer Science, Princeton

Eliezer Van Allen, MD

SAB, Oncology Indication Selection and Target ID

Professor of Medicine, Harvard Medical School Clinical Oncologist, Dana Farber Cancer Institute